Inflammatory bowel diseases

Symptomatic and Sonographic Improvement of Immune Checkpoint Inhibitor Enterocolitis With Risankizumab.

Inflammatory bowel diseases

Mei R, Pepe E, Oh DY, Tsai KK, Chugh R, Kattah MG

Opioid Use and Outcomes in Patients Hospitalized With Acute Severe Ulcerative Colitis.

Inflammatory bowel diseases

Karlovich N, McConnell R, Velayos F, Mahadevan U, Lewin S

Accurate, Robust, and Scalable Machine Abstraction of Mayo Endoscopic Subscores From Colonoscopy Reports.

Inflammatory bowel diseases

Silverman AL, Bhasuran B, Mosenia A, Yasini F, Ramasamy G, Banerjee I, Gupta S, Mardirossian T, Narain R, Sewell J, Butte AJ, Rudrapatna VA

VEDOLIZUMAB RESPONSE AND NON-RESPONSE IN ULCERATIVE COLITIS: INSIGHTS FROM SPATIAL TRANSCRIPTOMICS.

Inflammatory bowel diseases

Elvira Mennillo, Gyehyun Lee, Madison Lotstein, Jessica Tsui, Uma Mahadevan, Gabriela Fragiadakis, Alexis Combes, Michael Kattah

Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis.

Inflammatory bowel diseases

Dubinsky MC, Charles L, Selmaj KW, Comi G, Krakovich A, Rosen M, van der Woude CJ, Mahadevan U

Assessing the Impact of COVID-19 on IBD Outcomes Among Vulnerable Patient Populations in a Large Metropolitan Center.

Inflammatory bowel diseases

Odufalu FD, Sewell JL, Rudrapatna V, Somsouk M, Mahadevan U

Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro.

Inflammatory bowel diseases

Blaisdell A, Zhou Y, Kattah MG, Fisher SJ, Mahadevan U

Pages